0001415889-22-000847.txt : 20220128 0001415889-22-000847.hdr.sgml : 20220128 20220128163014 ACCESSION NUMBER: 0001415889-22-000847 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220126 FILED AS OF DATE: 20220128 DATE AS OF CHANGE: 20220128 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Laccona Nicholas CENTRAL INDEX KEY: 0001886497 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36845 FILM NUMBER: 22569280 MAIL ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Bellerophon Therapeutics, Inc. CENTRAL INDEX KEY: 0001600132 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473116175 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-574-4770 MAIL ADDRESS: STREET 1: 184 LIBERTY CORNER ROAD, SUITE 302 CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: Bellerophon Therapeutics LLC DATE OF NAME CHANGE: 20140213 4 1 form4-01282022_040102.xml X0306 4 2022-01-26 0001600132 Bellerophon Therapeutics, Inc. BLPH 0001886497 Laccona Nicholas 184 LIBERTY CORNER ROAD SUITE 302 WARREN NJ 07059 false true false false FINANCIAL OFFICER, (PFO & PAO) Restricted Stock Units 0 2022-01-26 4 A 0 36000 0 A Common Stock 36000 36000 D Each restricted stock unit represents the contingent right to receive, upon vesting of the unit, one share of Bellerophon common stock. The restricted stock units are scheduled to vest 50% on December 9, 2022 and 50% on December 8, 2023, as long as the reporting person remains in the service of Bellerophon through the respective vesting date. Not applicable. /s/ Nicholas Laccona 2022-01-28